Related Experiment Video
Updated: Apr 6, 2026
05:55
Delivery of Therapeutic Agents Through Intracerebroventricular ICV and Intravenous IV Injection in Mice
Published on: October 3, 2011
64.0K
Advances and challenges in developing a therapy for spinal muscular atrophy
Ryan S Anderton1, Frank L Mastaglia
1School of Health Sciences, University of Notre Dame Australia, 33 Phillimore Street, Fremantle, Western Australia 6959, Australia.
Expert Review of Neurotherapeutics
|July 23, 2015
Summary
Spinal muscular atrophy (SMA) is a severe childhood disease causing motor neuron loss and paralysis. Current research focuses on understanding SMA pathogenesis and developing effective treatments for patients.
Area of Science:
- Neurology
- Genetics
- Molecular Biology
Background:
- Spinal muscular atrophy (SMA) is a severe childhood-onset neuromuscular disorder.
- Characterized by motor neuron degeneration in the spinal cord, leading to progressive muscle weakness, atrophy, and paralysis.
- Currently, SMA is an incurable disease with no effective treatments available for patients.
Purpose of the Study:
- To review the current understanding of SMA pathogenesis.
- To outline recent therapeutic advances for SMA.
- To highlight the ongoing efforts in developing effective treatments for this devastating disease.
Main Methods:
- Review of existing scientific literature on SMA.
- Analysis of molecular mechanisms underlying SMA.
- Evaluation of preclinical and clinical studies on SMA therapies.
Main Results:
- Significant progress in understanding SMA's molecular basis over the past 20 years.
- Identification of the primary causative gene for SMA.
- Successful modeling of SMA in various animal species.
Conclusions:
- Despite advances in understanding SMA, effective treatments remain elusive.
- Ongoing research into pathogenesis and therapeutic strategies offers hope for future treatments.
- Further development is crucial to provide a successful therapy for SMA patients.
Related Concept Videos
01:21Satellite Stem Cells and Muscular Dystrophy
2.6K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.6K
01:20Myasthenia Gravis: Overview and Treatment
3.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.5K